Mesothelioma News and Research

RSS
Mesothelioma is a form of cancer that is almost always caused by previous exposure to asbestos. In this disease, malignant cells develop in the mesothelium, a protective lining that covers most of the body's internal organs. Most people who develop mesothelioma have worked on jobs where they inhaled asbestos particles, or have been exposed to high levels of asbestos fibers.
Study points to a new, effective treatment option for patients with mesothelioma

Study points to a new, effective treatment option for patients with mesothelioma

Promising new therapy for mesothelioma to enter a Phase I clinical trial

Promising new therapy for mesothelioma to enter a Phase I clinical trial

Long working hours are increasingly causing work-related deaths, global report says

Long working hours are increasingly causing work-related deaths, global report says

Scientists find new possibilities for treatment of lung cancers in 'never smokers'

Scientists find new possibilities for treatment of lung cancers in 'never smokers'

Promising data from early clinical trials of new anticancer therapies presented at ESMO Congress 2021

Promising data from early clinical trials of new anticancer therapies presented at ESMO Congress 2021

Survey: Nearly two-thirds of thoracic oncologists used telehealth for the first time during pandemic

Survey: Nearly two-thirds of thoracic oncologists used telehealth for the first time during pandemic

Neoadjuvant CPA followed by surgical resection and maintenance atezolizumab meets safety criteria

Neoadjuvant CPA followed by surgical resection and maintenance atezolizumab meets safety criteria

Study finds significant variability in treatment access for patients with malignant pleural mesothelioma

Study finds significant variability in treatment access for patients with malignant pleural mesothelioma

Study: Nearly one in five patients with malignant pleural mesothelioma contracted COVID-19

Study: Nearly one in five patients with malignant pleural mesothelioma contracted COVID-19

Rice University awarded $4 million CPRIT grant to establish Genetic Design and Engineering Center

Rice University awarded $4 million CPRIT grant to establish Genetic Design and Engineering Center

Drug combination found to be safe and effective in malignant peritoneal mesothelioma patients

Drug combination found to be safe and effective in malignant peritoneal mesothelioma patients

Selective immunotoxins may help treat liver fibrosis

Selective immunotoxins may help treat liver fibrosis

Mutation-signature–associated metrics predict cancer progression in patients

Mutation-signature–associated metrics predict cancer progression in patients

In poisoned Montana town, Warren Buffett-owned railroad accuses clinic of Medicare fraud

In poisoned Montana town, Warren Buffett-owned railroad accuses clinic of Medicare fraud

AI study on aggressive form of cancer could improve patient outcomes

AI study on aggressive form of cancer could improve patient outcomes

Checkpoint inhibition could offer an effective treatment option for patients with rare cancer

Checkpoint inhibition could offer an effective treatment option for patients with rare cancer

Underrepresentation in genomic databases may affect therapy selection for minority patients

Underrepresentation in genomic databases may affect therapy selection for minority patients

Phase 3 DREAM3R trial opens for malignant pleural mesothelioma

Phase 3 DREAM3R trial opens for malignant pleural mesothelioma

Study aims to identify proteomic determinants of treatment response in malignant pleural mesothelioma

Study aims to identify proteomic determinants of treatment response in malignant pleural mesothelioma

Nivolumab monotherapy is effective treatment option for relapsed malignant mesothelioma

Nivolumab monotherapy is effective treatment option for relapsed malignant mesothelioma